Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Oct 15, 2020 · 10-Q · 15 days after period end · 0001104659-20-115097
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$4.49M | -$5.63M | -$3.18M | -$2.40M |
| EPS Diluted | -$0.14 | — | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Oct 15, 2020 · 15 d after period end
